Dr. Andreu enjoyed a presentation about IBEC from Director Josep Samitier and Managing Director David Badía before visiting the labs in the Helix building, where group leaders Daniel Navajas, Pere Roca, Xavi Trepat, Pau Gorostiza and Ángel Raya explained some of their recent research results to him.
The visit came shortly after the publication of the ISCIII’s new Health Research and Development Strategy, which has a total budget of €110,918,010 and is their main instrument for strengthening research and human resources in the National Health System. The Strategy, which is aligned with the EU’s Horizon 2020 programme, includes nanomedicine and robotics among other research areas, so it was an ideal opportunity to discuss how IBEC can contribute to its objectives.
